• Facebook
  • Instagram
  • Twitter

Get Support – Call 1-888-MITO-411

  • Shop
  • Events
  • Donate
MitoAction

MitoAction

Support, Education, Outreach and Advocacy for Children and Adults Living with Mitochondrial Disease

  • Mitochondrial Disease
    • About Mito
      • New Patient Kit
      • Types of Mitochondrial Diseases
      • Symptoms
      • Treatment
      • Mito FAQ’s
      • Mitochondrial Disease News
    • Diagnosis & Care
      • Diagnosing Mitochondrial Disease
      • Find a Mito Doctor
      • What is a Mito Cocktail?
      • Mito Sick Protocol
      • Clinical Trials & Studies
    • Day to Day with Mito
      • Living with Mitochondrial Disease
      • Care Management
      • Managing Your Energy
      • Traveling with Mito
      • Navigating COVID-19
    • For Medical Professionals
      • Mitochondrial Care Network
      • Monthly Expert Series
  • Fatty Acid Oxidation Disorders
    • About FAODs
      • Types of FAOD
      • Symptoms
      • Diagnosis
      • Treatment
    • FAOD Programs and Support
      • New Patient Kit
      • FAOD Support Calls
      • FAOD Experts Series
      • FAOD Resources
      • International Metabolic Conference
  • Programs & Support
    • Support
      • Mito411
      • MitoAction Memories
      • MitoPlaydates
      • MitoSocials
      • MitoChampions
      • Support Calls
      • Positive Peach Packages
    • Programs
      • Dalia’s Wish
      • Matthew Harty Camper Fund
      • Marcel’s Way Family Fund
      • MitoSantas
      • MyMito App
    • Education
      • Monthly Expert Series
      • Wondering Wednesdays
      • Energy In Action Podcast
      • Energy 4 Education
      • Patient Education Forums
      • International Metabolic Conference
    • Resources & Planning
      • Health Insurance
      • Disability Benefits
      • Mobility Devices
      • Vehicle Modification
      • Estate Planning
      • Medical Child Abuse
  • Join the Cause
    • Giving
      • Donate
      • Honor and Memorial Giving
      • Another Helping
      • Matching Gifts
      • Shop for MitoAction
      • Giving Tuesday – Ways to Give
    • Events
      • International Metabolic Conference
      • MitoAction Energy Walks
      • Sandra K. Russell Derby Day Benefit for Mito
      • Matthew Harty Camper Fund Events
    • Volunteer
      • Host a MitoSocial
      • Host a MitoPlaydate
      • Create a Fundraiser
      • MitoChampions
      • Share Your Ideas
    • Raise Your Voice
      • Take Legislative Action
      • Mitochondrial Disease Awareness Week
      • Light a Light
  • About Us
    • Contact Us
    • Connect on Social
    • Our Team
    • Meet Our Partners
    • Newsletter Signup
  • Show Search

CPT2: Carnitine Palmitoyltransferase 2 Deficiency

Nov 4, 2022

  • General
  • Genetics
  • Frequency
  • Symptoms
  • Diagnosis
  • Treatment
  • Clinical Trials
  • Resources

General Info

Overview

Carnitine palmitoyltransferase 2 deficiency is a type of genetic condition where an enzyme that helps to prepare long-chain fatty acids for breakdown once they enter the mitochondria is not able to function properly. This prevents the body from creating needed energy during times of stress, illness, and fasting, which can lead to medical symptoms. The body usually gets its energy by breaking down, or burning, fats and sugars. People with FAODs cannot properly break down certain types of fats.

Alternative Names

CPT2

CPT2a deficiency

Genetics

Affected Genes

CPT2

Inheritance Type(s)
  • Autosomal recessive
Cause and Genetics

People usually have two copies of the CPT2 gene, one inherited from each parent. CPT2 deficiency occurs when there are changes in both copies of the CPT2 gene (autosomal recessive inheritance). Someone who has a change in only one copy of the CPT2 gene is called a carrier, and they usually do not have any medical symptoms. If both parents are carriers, there is a 1 in 4 chance with each pregnancy that their child will have CPT2 deficiency.

Frequency

Frequency - More Information

CPT2 deficiency is the most common FAOD and usually presents in a mild form. Over 300 mild cases have been reported worldwide, and it is thought that CPT2 deficiency is under-recognized.

Affected Biological Gender

Both Male and Female

Signs and Symptoms

CPT2 deficiency can occur in both mild and severe forms. Whether your child was diagnosed via newborn screening may also affect when, if, and how these symptoms present. Always check with your doctor if your child is doing something out of “their” normal, as every child may present with symptoms a little differently.

Patients with the severe form of CPT2 typically present as a baby. Signs and symptoms may include:

  • Extreme tiredness (lethargy)
  • Irritability
  • Poor appetite
  • A weakened heart muscle (cardiomyopathy)
  • Abnormal heart rhythms (arrhythmias)
  • Total failure of heart and lung function
  • Low blood sugar with lack of ketones (hypoketotic hypoglycemia)
  • Coma within days or weeks after birth (as a result of low blood sugar)

Patients with the mild form of CPT2 deficiency usually present in adolescence or early adulthood. Signs and symptoms may include:

  • Brownish red urine indicating muscle breakdown (myoglobinuria)
  • Muscle weakness or pain after exercise or other physical stress
  • Muscle breakdown (rhabdomyolysis)
  • High blood ammonia (hyperammonemia)
  • Enlarged liver (hepatomegaly), especially when sick
  • Enlarged, weakened heart (cardiomyopathy)
  • Low blood sugar with lack of ketones (hypoketotic hypoglycemia)

Diagnosis

CPT2 deficiency can be diagnosed by:

  • Clinical examination due to the signs and symptoms outlined above
  • Measuring biochemical markers in the blood or urine (including acylcarnitine analysis and organic acid analysis)
  • Measuring the amount of CPT2 activity in the blood or skin cells
  • Performing a genetic test to look for changes in the CPT2 gene
  • Prenatal testing of amniotic fluid or chorionic villi if there is a known family history of CPT2 deficiency
Newborn Screening: Recommended Uniform Screening Panel (RUSP)

Yes

Newborn Screening - More Information
PT2 deficiency can be identified by newborn screening; however, some mild cases may be missed during routine screening. If there is a known family history of CPT2 deficiency, or if parents know they are known carriers, prenatal testing can be performed.

Treatment

Treatment and Management

Treatment and management of CPT2 deficiency may include:

  • Regular eating schedules to prevent of low blood sugar (hypoglycemia)
  • Continuous feeding directly into the stomach in extreme cases
  • Possible nutritional supplements like medium-chain triglycerides (e.g., MCT oil)
  • Possible pharmacological treatment using triheptanoin (Dojolvi)

Parents should call their healthcare provider immediately if babies show symptoms like excessive sleepiness, vomiting, diarrhea, a fever, poor appetite, or an infection. Medical treatment should be sought immediately if there is loss of consciousness or severe confusion (decompensation), as these are signs of dangerously low blood sugar.

Patients should discuss the appropriate preparation for anesthesia with their metabolic team.

Clinical Trials

For specific details on clinical trials visit the MitoAction Clinical Trial page or www.clinicaltrials.gov.

Resources

  • Carnitine palmitoyltransferase 2 deficiency – About the Disease – The  National Institutes of Health
  • CPT2 Deficiency | Fatty Acid Oxidation Disorders Diagnosis – The INFORM Network
  • Carnitine palmitoyltransferase 2 deficiency – National Organization for Rare Disorders (NORD)

Connecting with others impacted by a rare disease allows for vital information to be shared about day-to-day life, prevents isolation, and gives hope. Please contact MitoAction for peer support opportunities at 888-MITO-411 or email mito411@mitoaction.org.

Other resources we recommend are:

  • New Patient Kit for Mitochondrial Conditions
  • Planning for Emergencies
  • Monthly Expert Series
  • Energy in Action Podcast

Download this Fact Sheet

MitoAction does not provide medical advice, diagnosis, treatment, or legal advice. It is essential that all those living with or caring for someone with a Mitochondrial or FAOD disease have an emergency protocol letter. These letters, which are written and signed by a doctor, share details about prescribed treatment during crises and in emergency room settings. Always check with your doctor if you or your child has concerns as everyone may present with symptoms differently. Before beginning any treatment or therapy, please consult with your physician.

Last Updated: 11/15/2022

Upcoming
Events

View All
Oct 5
6:00 pm - 7:00 pm Event Series

CPEO & Me

Oct 6
1:15 pm - 2:15 pm

Weekly Support Call

Oct 10
8:30 pm - 9:30 pm Event Series

Our Space: A space for young adults with Mito and FAODs to connect and network

View Calendar

Expert
Series

View All

Upcoming Presentations

Nov 1
7:00 pm - 8:00 pm

Expert Series: LCHADD Retinopathy Update: Moving Toward a Treatment

Nov 3
12:00 pm - 1:00 pm

Expert Series: Immune Cell Function in Mitochondrial Disease

View Calendar

Last Presentation

Expert Series: At the crossroad of mitochondrial disease and mitochondrial dysfunction
Presented July 25, 2023

P.O. Box 310
Novi, MI 48376
(888) 648-6228
info@mitoaction.org

  • Support
  • Resources
  • Donate
  • Events
  • Subscribe
©2023 MitoAction. All Rights Reserved. Website by ThinkGenetic, Inc.

Privacy Policy. Terms of Use.